From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Nanoco – “broadening our efforts to seek out other potential new customers”… so still “lack of current commercial contracts” then!

By Steve Moore | Thursday 15 August 2019


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Nanoco Group (NANO) has updated including “unaudited revenues of £7.3m for the year ended 31 July 2019 were more than double FY18 and slightly ahead of market consensus expectations… cash position at 31 July 2019 was £7.0m, an increase of £0.8m since 31 January 2019” and “the completion of the new Runcorn facility and the waiver of the contract liability leaves the group with a significantly expanded asset base and production capability across a wider range of market sectors”. However, the shares remain sub 12p – down from circa 40p as recently as June!

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 04:43:59